{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"GOG GYN-LIVE - INDUSTRY SUPPORTED SYMPOSIA","title":"Beyond the Image: New Opportunities in Gynecologic Cancer Testing","html":"","width":"100%","height":180,"duration":4047,"description":"Minimal Residual Disease (MRD) testing using circulating tumor DNA (ctDNA) has emerged as a promising tool for improving the management of gynecologic malignancies, including endometrial, ovarian, and cervical cancers. This 90-minute course explores the evolving role of ctDNA in identifying disease recurrence and assessing treatment response—potentially earlier than imaging or traditional biomarkers. Participants will receive an in-depth overview of the biological basis of ctDNA detection, the current clinical evidence supporting its utility, and its integration into clinical workflows. Case-based discussions will illustrate real-world applications, showcasing how ctDNA can optimize decisions on surveillance and therapeutic strategy. The program will also critically assess limitations and challenges of ctDNA-based MRD testing, including issues with sensitivity, false positives, access, and cost. In alignment with a fair and balanced approach, the course will also explore other MRD detection modalities such as radiologic imaging, CA-125, and histopathology, highlighting comparative strengths and contexts for use. The program engages clinicians to learn how to interpret ctDNA MRD data and apply it effectively within a multidisciplinary care framework.","thumbnail_url":"https://img.transistorcdn.com/3bz-ibWx2NG6B5urAYFqgf6Yb0TjFLbgjsOstM1hqeE/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMTEx/ZDRkYmY0ZGNlNWQ3/Y2RmMjFmMzAwOTY3/OGM2OS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}